All promise but no real sales or revenues, need execution not hot air, Holders been hurt, underwater CR cant get anyworse. GLTH watching on sidelines
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%